2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Molecular basis <strong>of</strong> Mendelian disorders<br />
common form <strong>of</strong> the disease, and is caused by a deficiency in the<br />
cytosolic protein phosphomannomutase (EC 5.4.2.8, PMM 2). The aim<br />
<strong>of</strong> this work has been the functional analysis <strong>of</strong> 12 missense changes<br />
identified in a cohort <strong>of</strong> Spanish patients in order to provide clues to understand<br />
the phenotype-genotype correlation and to investigate new<br />
therapeutic approaches. First we have studied the PMM2 protein stability<br />
and gene expression in the fibroblast cell lines. All fibroblasts cell<br />
lines presented lower amount <strong>of</strong> PMM2 mutant protein while no effect<br />
on mRNA stability was detected. The prokaryotic in vitro studies have<br />
demonstrated that all new changes are disease-causing mutations and<br />
have revealed the presence <strong>of</strong> null mutations (R123Q, R141H, F157S,<br />
P184T, F207S and D209G), mutations with residual activity ranging<br />
between 44-54% (L32R, T118S, T237M and P113L) and mutations<br />
with residual activity ranging between 16-21% (D65Y and V44A). Most<br />
<strong>of</strong> the patients are functional hemyzygous for a null mutation and a<br />
mutation with intermediate residual activity -usually associated with a<br />
moderate form <strong>of</strong> the disease- or with a mutation with higher residual<br />
activity usually associated with a milder clinical phenotype. The protein<br />
stability assays identified at least six changes (V44A, D65Y, F157S,<br />
P184T, F207S and T237M) with decreased amount <strong>of</strong> immunorreactive<br />
PMM2 protein and decreased half life compared to wild type,<br />
opening up therapeutic possibilities by pharmacological chaperones in<br />
several <strong>of</strong> our cohort <strong>of</strong> patients.<br />
P12.029<br />
HLA polymorphism in celiac disease Romanian children<br />
O. N. Belei 1 , I. Simedrea 1 , L. Tamas 2 , C. Daescu 1 , T. Marcovici 1 , F. Antonie 3 , G.<br />
Brad 3 , D. Mihailov 4 ;<br />
1 First Pediatric Clinic, University <strong>of</strong> Medicine and Pharmacy “Victor Babes”,<br />
Timisoara, Romania, 2 Biochemistry Departement, University <strong>of</strong> Medicine and<br />
Pharmacy “Victor Babes”, Timisoara, Romania, 3 Emergency Children Hospital<br />
Louis Turcanu, Timisoara, Romania, 4 Third Pediatric Clinic, University <strong>of</strong> Medicine<br />
and Pharmacy “Victor Babes”, Timisoara, Romania.<br />
Introduction: Celiac disease (CD) is an immune-mediated enteropathy<br />
caused by a permanent sensitivity to gluten in genetically susceptible<br />
individuals (DQ2 or DQ8 HLA haplotype). Objective: To correlate the<br />
clinical forms <strong>of</strong> CD with villous injury severity, IgA anti-tissue transglutaminase<br />
(tTG) antibodies serum level and DQ2 / DQ8 haplotype.<br />
Material and Methods: We recruited 2 lots: lot 1 - 24 children diagnosed<br />
with CD by mass screening in subjects associating risk factors<br />
and lot 2 - 24 healthy controls matched with sex and age. HLA DQ2<br />
and DQ8 alleles were typed by PCR-SSP, IgA tTG assessment was<br />
made using ELISA and villous injury was classified using Marsh score.<br />
Results: From 24 CD patients, 15 associated atypical or silent form<br />
<strong>of</strong> disease and only 9 associated the typical form. Haplotype analysis<br />
showed that the main combination observed was DQ2 in cis conformation<br />
(DQA1*0501 and DQB1*0201 alleles) in 14 patients from lot<br />
1 and in one subject from lot 2. We found a strong correlation between<br />
IgA tTG serum level and villous injury degree (p=0,03), but there<br />
was no statistically significant correlation between the clinical forms<br />
<strong>of</strong> disease, Marsh score and the distribution <strong>of</strong> the different alleles (p<br />
= 0,07). Conclusion: We confirmed in this study the high frequency<br />
<strong>of</strong> DQ2 haplotype in CD patients. Presence <strong>of</strong> HLA DQ2 or DQ8 is<br />
mandatory but not sufficient for developing gluten enteropathy. HLA<br />
polymorphism seems to have no impact on clinical forms <strong>of</strong> CD.<br />
1<br />
P12.030<br />
A large family with spinocerebellar ataxia type 6 in iran: a<br />
clinical and genetic study<br />
R. Vazifehmand Roodposhtie 1 , H. Shimazaki 2 , V. Reza 3 , H. Hassan 3 , K.<br />
Reza 4 , S. Sassan 3 , H. Shamsodin 5 , A. Fatemeh 4 , Y. Ouyang 2 , J. Honda 6 , I.<br />
Nakano 6 , Y. Takiyama 2 ;<br />
1 Shahid Beheshti Medical University, Tehran, Islamic Republic <strong>of</strong> Iran, 2 Jichi<br />
Medical University, Neurology, Jichi, Japan, 3 Shaheed Beheshti University <strong>of</strong><br />
Medical Sciences and Health Services, Department <strong>of</strong> Anatomical Sciences,<br />
Tehran, Islamic Republic <strong>of</strong> Iran, 4 The Social Welfare and Rehabilitation Sciences<br />
University, Genetic Research Center, Tehran, Islamic Republic <strong>of</strong> Iran,<br />
5 Qom University <strong>of</strong> Medical Sciences, Department <strong>of</strong> Neurological Sciences,<br />
Tehran, Islamic Republic <strong>of</strong> Iran, 6 Jichi Medical University, Department <strong>of</strong> Neurology,<br />
Jichi, Japan.<br />
The authors describe a large Iranian family with autosomal dominant<br />
cerebellar<br />
ataxia, which included 14 patients in four generations. We examined<br />
seven patients who<br />
had expanded CAG repeats in the CACNA1A gene with repeat instability<br />
(24 and 25<br />
repeats). Although all patients showed cerebellar ataxia, each patient<br />
exhibited peripheral<br />
neuropathy or spasticity indicating intrafamilial phenotypic variability.<br />
This is the first<br />
report <strong>of</strong> SCA6 in Iran, and suggests the worldwide distribution <strong>of</strong><br />
SCA6.Key words: Spinocerebellar ataxia , SCA6 , Autosomal Dominant<br />
, Iran<br />
P12.031<br />
somatic and germline mosaicism in a carrier <strong>of</strong> a large deletion<br />
at Xp21 locus leading to chronic granulomatous disease and mc<br />
leod syndrome<br />
C. Kannengiesser 1,2 , N. Mahlaoui 3 , D. Henry 1 , E. Al Ageeli 1 , S. Quentin 4,5 , D.<br />
Moshous 3 , M. de Blois 6 , A. Auvrignon 7 , f. Monceaux 8 , S. Perdereaux 8 , S. Briault<br />
9 , M. Gougerot-Pocidalo 10,2 , B. Grandchamp 1,2 ;<br />
1 AP-HP, Bichat, génétique, Paris, France, 2 Université Paris Diderot U773,<br />
France, 3 AP-HP, Necker, Immunologie, Paris, France, 4 AP-HP, Plate forme<br />
génomique IUH Saint Louis, Paris, France, 5 Université Paris Diderot, Paris,<br />
France, 6 AP-HP, Necker, Cytogénétique, Paris, France, 7 AP-HP, Trousseau,<br />
hématologie oncologie pédiatrique, Paris, France, 8 CHR Orléans, Pédiatrie, Orléans,<br />
France, 9 CHR Orléans, cytogénétique, Orléans, France, 10 AP-HP, Bichat,<br />
immunologie hématologie, Paris, France.<br />
The proband is a boy who presented when he was three months old<br />
with a granulomatous lymphadenitis. Nitroblue tetrazolium reduction<br />
assay (NBT test) was consistent with the diagnosis <strong>of</strong> chronic granulomatous<br />
disease (CGD), a immunodeficiency disease resulting from<br />
mutation in genes encoding the subunits <strong>of</strong> NADPH oxidase complex :<br />
CYBA, CYBB, NCF1 and NCF2 (Online Mendelian Inheritance in man<br />
MIM#s 233690, 306400, 233700, 233710). Western blot analysis <strong>of</strong><br />
the NADPH oxidase subunits revealed absence <strong>of</strong> expression <strong>of</strong> GP-<br />
91phox encoded by CYBB (Xp21). The patient had also acanthocytosis<br />
suggesting a McLeod syndrome that is caused by a mutation in XK<br />
locus also at Xp21. We hypothesized a contiguous gene deletion for<br />
XK and CYBB. We confirmed the presence <strong>of</strong> a large deletion <strong>of</strong> 1.8Mb<br />
<strong>of</strong> CYBB by CGH array and characterized precisely the breakpoints by<br />
sequencing a PCR fragment generated using primers from each side<br />
<strong>of</strong> the deletion. Using quantitative PCR at the CYBB locus and the<br />
specific PCR amplification <strong>of</strong> the deleted X chromosome, we showed<br />
that the mother had a somatic mosaicism and that an half sister <strong>of</strong> the<br />
proband was a carrier <strong>of</strong> the deletion. Segregation analysis <strong>of</strong> microsatellite<br />
markers in this family (including 3 additional half brothers <strong>of</strong><br />
the proband) revealed that the deletion was either present or absent<br />
on the same X-chromosomal region inherited from the mother, thus<br />
indicating a germline mosaicism. We provide here molecular evidence<br />
for the occurrence <strong>of</strong> somatic and germline mosaicism in a carrier <strong>of</strong><br />
CGD and McLeod syndrome.<br />
P12.032<br />
chiari malformation type i: Linkage to chromosome 16p13.3 in a<br />
large spanish kindred<br />
E. Cuenca-Leon 1 , A. Urbizu 1 , S. Boronat 1 , E. Solana 2 , T. Vendrell 3 , E.<br />
Vázquez 4 , M. Poca 2 , A. Macaya 1 ;<br />
1 Grup de Recerca en Neurologia Infantil, Institut de Recerca Vall d’Hebron,<br />
Barcelona, Spain, 2 Servei de Neurocirurgia, Hospital Universitari Vall d’Hebron,<br />
Barcelona, Spain, 3 Unitat de Genètica Clínica, Hospital Universitari Vall<br />
d’Hebron, Barcelona, Spain, 4 Institut de Diagnòstic per la Imatge, Hospital<br />
Universitari Vall d’Hebron, Barcelona, Spain.<br />
Background: Chiari malformation type I (CMI) is a mesodermal anomaly<br />
that may cause severe and progressive neurological deficits. The<br />
main feature is the ectopia <strong>of</strong> the cerebellar tonsils which are downwardly<br />
displaced through the foramen magnum. Familial aggregation,<br />
twin studies and cosegregation with known genetic syndromes support<br />
that at least in a subset <strong>of</strong> CMI patients there is a substantial genetic<br />
contribution, but up to date no genetic loci or genes have been convincingly<br />
linked to CMI.<br />
Objective: To map the disease-causing gene in a large Spanish kindred<br />
with Chiari malformation type I (CMI) with a mendelian pattern<br />
<strong>of</strong> inheritance.<br />
Methods: DNA samples from 31 family members were obtained.